FDAnews Drug Daily Bulletin

MEDIMMUNE FORMS NEW CANCER RESEARCH PARTNERSHIP

Dec. 9, 2005
A A

MedImmune Inc. (MEDI.O: Quote, Profile, Research) said on Thursday it has formed a new partnership to expand its line of cancer treatments. The Gaithersburg, Maryland-based biotechnology company signed an agreement with the not-for-profit Burnham Institute for Medical Research to develop drugs targeting a family of proteins known as EphA and EphB, which are believed to play a role in uncontrolled tumor growth in many cancers.

Reuters (http://yahoo.reuters.com/financeQuoteCompanyNewsArticle.jhtml?duid=mtfh29238_2005-12-08_14-41-01_n08376367_newsml)